Treatment Options for Fibromyalgia Patients

Fibromyalgia is a chronic condition that causes widespread pain, increased sensitivity to pain, and psychological symptoms. Treatment options can be divided into generic and patient-focused treatments. Aerobic exercise is a first-line, generic treatment that has been shown to improve symptoms of pain and physical function. Cognitive behavioral therapy (CBT) is a patient-focused treatment that may be considered for patients with pain-related depression, anxiety, catastrophizing, and/or passive or active coping strategies. Anaerobic exercise should be avoided as it may increase inflammation and oxidative stress. Duloxetine and pregabalin are pharmacotherapy options for patients with severe pain or sleep disturbance, but only after non-pharmacological treatments have failed. It is important to tailor treatment to each patient’s individual needs.

Treatment Options for Fibromyalgia Patients

Understanding the Side-Effects of Tamoxifen Therapy

Tamoxifen is a medication used in the prevention and treatment of breast cancer. As a selective ER modulator, it has both oestrogenic and anti-oestrogenic actions depending on the target tissue. While it is effective in its intended use, tamoxifen therapy can also cause side-effects.

One of the most common side-effects of tamoxifen therapy is hot flashes and sweats. Other side-effects include changes in menstrual patterns, loss of sex drive, nausea, visual problems, muscle ache, and fatigue. However, hirsutism (abnormal or excessive hair growth) is not a commonly occurring side-effect of tamoxifen. Thinning of the hair may occur, but this usually resolves on cessation of treatment.

Contrary to popular belief, weight gain and not weight loss is a commonly associated side-effect of tamoxifen treatment. Additionally, there is a risk of hypercoagulability and thromboembolic events with tamoxifen therapy, as opposed to bleeding. Haematuria (blood in urine) is not commonly associated with the use of tamoxifen.

In conclusion, while tamoxifen is an effective medication for the prevention and treatment of breast cancer, it is important to be aware of its potential side-effects. Patients should discuss any concerns with their healthcare provider and report any unusual symptoms experienced during treatment.

Annual Monitoring for Diabetes in Women with Polycystic Ovary Syndrome

Women with polycystic ovary syndrome (PCOS) are at an increased risk of developing type 2 diabetes mellitus. Therefore, it is important to monitor these patients for diabetes. The monitoring approach depends on the patient’s risk stratification, which is determined by factors such as BMI, family history of diabetes, and personal history of gestational diabetes.

For patients with evidence of impaired glucose tolerance, defined as a fasting glucose of < 7.0 mmol/l and a 2-hour OGTT of ≥ 7.8 but < 11.1 mmol/l, dietary and weight loss advice should be given, and a repeat glucose tolerance test is indicated annually. For patients with a normal glucose tolerance test, with a BMI of < 30 kg/m2, no family history of diabetes, and no personal history of gestational diabetes, annual random fasting glucose testing is appropriate. If the result is ≥ 5.6 mmol/l, then a glucose tolerance test should be performed. For patients with a BMI of ≥ 30 kg/m2, annual glucose tolerance testing is recommended. If diabetes is suspected based on symptoms such as polyuria, polydipsia, and weight loss, a random serum glucose of ≥ 11.0 mmol/l or a fasting glucose of ≥ 7.0 mmol/l is diagnostic. In asymptomatic patients, two samples of fasting glucose of ≥ 7.0 mmol/l are adequate for diagnosis. In conclusion, annual monitoring for diabetes is important in women with PCOS to prevent complications and morbidity associated with type 2 diabetes mellitus. The monitoring approach should be tailored to the patient’s risk stratification.

Socioeconomic deprivation, maternal alcohol/tobacco use, and maternal age under 20 are all associated with gastroschisis.

While gastroschisis and omphalocele have similar presentations, gastroschisis refers to a defect located to the side of the umbilicus, while omphalocele refers to a defect in the umbilicus itself.

Foetal alcohol syndrome is characterized by a small head, flattened philtrum, and thin upper lip.

Anencephaly is a neural tube defect that results in the absence of the brain, skull, and scalp.

Gastroschisis and exomphalos are both types of congenital visceral malformations. Gastroschisis refers to a defect in the anterior abdominal wall located just beside the umbilical cord. In contrast, exomphalos, also known as omphalocoele, involves the protrusion of abdominal contents through the anterior abdominal wall, which are covered by an amniotic sac formed by amniotic membrane and peritoneum.

When it comes to managing gastroschisis, vaginal delivery may be attempted, but newborns should be taken to the operating theatre as soon as possible after delivery, ideally within four hours. As for exomphalos, a caesarean section is recommended to reduce the risk of sac rupture. In cases where primary closure is difficult due to lack of space or high intra-abdominal pressure, a staged repair may be undertaken. This involves allowing the sac to granulate and epithelialise over several weeks or months, forming a shell. As the infant grows, the sac contents will eventually fit within the abdominal cavity, at which point the shell can be removed and the abdomen closed.

Overall, both gastroschisis and exomphalos require careful management to ensure the best possible outcome for the newborn. By understanding the differences between these two conditions and the appropriate steps to take, healthcare professionals can provide effective care and support to both the infant and their family.

A laryngeal mask is not suitable for non-fasted patients as it provides poor control against reflux of gastric contents, which can lead to aspiration during anaesthesia induction. Therefore, an endotracheal tube with an inflated cuff is a better option as it can protect the trachea and bronchial tree from aspirate. Ketamine is not contraindicated in this patient as it does not cause malignant hyperpyrexia, which is a concern due to the patient’s family history. Non-depolarising muscle relaxants are also not a concern for malignant hyperpyrexia.

Airway Management Devices and Techniques

Airway management is a crucial aspect of medical care, especially in emergency situations. In addition to airway adjuncts, there are simple positional manoeuvres that can be used to open the airway, such as head tilt/chin lift and jaw thrust. There are also several devices that can be used for airway management, each with its own advantages and limitations.

The oropharyngeal airway is easy to insert and use, making it ideal for short procedures. It is often used as a temporary measure until a more definitive airway can be established. The laryngeal mask is widely used and very easy to insert. It sits in the pharynx and aligns to cover the airway, but it does not provide good control against reflux of gastric contents. The tracheostomy reduces the work of breathing and may be useful in slow weaning, but it requires humidified air and may dry secretions. The endotracheal tube provides optimal control of the airway once the cuff is inflated and can be used for long or short-term ventilation, but errors in insertion may result in oesophageal intubation.

It is important to note that paralysis is often required for some of these devices, and higher ventilation pressures can be used with the endotracheal tube. Capnography should be monitored to ensure proper placement and ventilation. Each device has its own unique benefits and drawbacks, and the choice of device will depend on the specific needs of the patient and the situation at hand.

Pregnant women who have a history of VTE should receive LMWH throughout their pregnancy and up to 6 weeks after giving birth to prevent clotting. Warfarin is not recommended during pregnancy due to its teratogenic effects, and LMWH is preferred due to its lower side effect profile and reduced need for monitoring.

Venous Thromboembolism in Pregnancy: Risk Assessment and Prophylactic Measures

Pregnancy increases the risk of developing venous thromboembolism (VTE), a condition that can be life-threatening for both the mother and the fetus. To prevent VTE, it is important to assess a woman’s individual risk during pregnancy and initiate appropriate prophylactic measures. This risk assessment should be done at the first antenatal booking and on any subsequent hospital admission.

Women with a previous history of VTE are automatically considered high risk and require low molecular weight heparin throughout the antenatal period, as well as input from experts. Women at intermediate risk due to hospitalization, surgery, co-morbidities, or thrombophilia should also be considered for antenatal prophylactic low molecular weight heparin.

The risk assessment at booking should include factors that increase the likelihood of developing VTE, such as age over 35, body mass index over 30, parity over 3, smoking, gross varicose veins, current pre-eclampsia, immobility, family history of unprovoked VTE, low-risk thrombophilia, multiple pregnancy, and IVF pregnancy.

If a woman has four or more risk factors, immediate treatment with low molecular weight heparin should be initiated and continued until six weeks postnatal. If a woman has three risk factors, low molecular weight heparin should be initiated from 28 weeks and continued until six weeks postnatal.

If a diagnosis of deep vein thrombosis (DVT) is made shortly before delivery, anticoagulation treatment should be continued for at least three months, as in other patients with provoked DVTs. Low molecular weight heparin is the treatment of choice for VTE prophylaxis in pregnancy, while direct oral anticoagulants (DOACs) and warfarin should be avoided.

In summary, a thorough risk assessment and appropriate prophylactic measures can help prevent VTE in pregnancy, which is crucial for the health and safety of both the mother and the fetus.

Differential Diagnosis: Addisonian Crisis and Other Conditions

Addisonian crisis is a condition caused by adrenal insufficiency, often due to autoimmune disease or other factors such as tuberculosis or adrenal haemorrhage. Symptoms are vague and insidious, including weight loss, depression, anorexia, and gastrointestinal upset. Diagnosis is made through a short ACTH stimulation test. Emergency treatment involves IV hydrocortisone and fluids, while long-term treatment involves oral cortisol and mineralocorticoid. Any stressful activity should lead to an increase in steroid dosage.

Other conditions, such as insulin overdose, salicylate overdose, meningococcal septicaemia, and paracetamol overdose, may present with similar symptoms but can be ruled out based on the clinical information given. Insulin overdose can cause low glucose levels due to loss of the anti-insulin effect of cortisol. Salicylate overdose can cause a range of symptoms, but the ones described here are not suggestive of this condition. Meningococcal septicaemia may present with hypotension and tachycardia, but the remaining features do not fit this diagnosis. Paracetamol overdose typically presents with liver toxicity symptoms, which are not described in the given information. Therefore, the specific symptoms described are indicative of an Addisonian crisis.

Glycopeptides and their Mechanism of Action

Glycopeptides are a type of antibiotic that work by preventing the synthesis of the bacterial cell wall. This is achieved through steric hindrance of peptidoglycans, which are essential components of the cell wall. By inhibiting the formation of peptidoglycans, glycopeptides prevent the bacteria from building a strong and stable cell wall, ultimately leading to cell death.

The mechanism of action of glycopeptides is unique compared to other antibiotics, as they specifically target the cell wall rather than other cellular processes. This makes them particularly effective against gram-positive bacteria, which have a thicker peptidoglycan layer compared to gram-negative bacteria. However, some bacteria have developed resistance to glycopeptides through various mechanisms, such as modifying the target site or producing enzymes that degrade the antibiotic. Despite this, glycopeptides remain an important class of antibiotics in the treatment of bacterial infections.

In cases of paracetamol overdose, liver transplantation may be considered if the arterial pH remains below 7.3 for more than 24 hours after ingestion. Other factors such as creatinine levels, encephalopathy grade, and INR must also be significantly abnormal to warrant transplantation.

Paracetamol overdose management guidelines were reviewed by the Commission on Human Medicines in 2012. The new guidelines removed the ‘high-risk’ treatment line on the normogram, meaning that all patients are treated the same regardless of their risk factors for hepatotoxicity. However, for situations outside of the normal parameters, it is recommended to consult the National Poisons Information Service/TOXBASE. Patients who present within an hour of overdose may benefit from activated charcoal to reduce drug absorption. Acetylcysteine should be given if the plasma paracetamol concentration is on or above a single treatment line joining points of 100 mg/L at 4 hours and 15 mg/L at 15 hours, regardless of risk factors of hepatotoxicity. Acetylcysteine is now infused over 1 hour to reduce adverse effects. Anaphylactoid reactions to IV acetylcysteine are generally treated by stopping the infusion, then restarting at a slower rate. The King’s College Hospital criteria for liver transplantation in paracetamol liver failure include arterial pH < 7.3, prothrombin time > 100 seconds, creatinine > 300 µmol/l, and grade III or IV encephalopathy.

Important Points to Remember about Fetomaternal Haemorrhage

Following the delivery of a baby, it is crucial to determine the degree of fetomaternal haemorrhage (FMH) in a D negative mother. This is done by analyzing a blood sample to adjust the dose of anti-D in the mother if she has delivered a D positive child. It is important to note that D positive and D negative women have the same likelihood of developing antibodies to other red cell antigens. Therefore, all pregnant women should undergo a blood group and antibody screen in their first trimester or at the time of presentation, whichever comes first. The fetal Rh type is determined by the Rh typing of both the mother and father. Additionally, maternal antibody titres are indicative of the degree of haemolytic disease of the newborn (HDN). For more information on the management of women with red cell antibodies during pregnancy, refer to the Royal College of Obstetricians and Gynaecologists (RCOG) Green-top Guideline No. 65.